ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

HAE Haemonetics Corp

84.08
-0.57 (-0.67%)
01 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Haemonetics Corp NYSE:HAE NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  -0.57 -0.67% 84.08 85.2924 82.885 84.75 959,786 01:00:00

Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day

21/02/2024 10:55pm

PR Newswire (US)


Haemonetics (NYSE:HAE)
Historical Stock Chart


From Dec 2023 to Jun 2024

Click Here for more Haemonetics Charts.

BOSTON, Feb. 21, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at Citi's 2024 Unplugged Medtech and Life Sciences Access Day on Thursday, February 29, 2024 at 8:45 a.m. ET.

The public may access a live webcast of the fireside chat at Haemonetics' Investor Relations website or at the following link: https://kvgo.com/unplugged-medtech-life-sciences-access-day/haemonetics-corp-feb-2024. A replay of the recorded webcast will become accessible 12 hours after the event and will be available for 90 days on Haemonetics' Investor Relations website.

About Haemonetics

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:


Olga Guyette, Sr. Director-Investor Relations & Treasury

David Trenk, Manager-Investor Relations

(781) 356-9763

(203) 733-4987

olga.guyette@haemonetics.com

david.trenk@haemonetics.com



Media Contact:


Josh Gitelson, Director-Global Communications


(781) 356-9776


josh.gitelson@haemonetics.com 


Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-to-present-at-citis-2024-unplugged-medtech-and-life-sciences-access-day-302068093.html

SOURCE Haemonetics Corporation

Copyright 2024 PR Newswire

1 Year Haemonetics Chart

1 Year Haemonetics Chart

1 Month Haemonetics Chart

1 Month Haemonetics Chart